Early Evidence of Anti-Pd-1 Activity in Enzalutamide-Resistant Prostate Cancer

Oncotarget - United States
doi 10.18632/oncotarget.10547
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Evidence for the Efficacy of Enzalutamide in Postchemotherapy Metastatic Castrate-Resistant Prostate Cancer

Therapeutic Advances in Urology
Urology
2013English

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology
Oncology
2013English

Prostate Cancer Responds to Anti–PD-1–ctla4 Combo

Cancer Discovery
Oncology
2019English

Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer

Japanese Journal of Urology
Urology
2016English

A Pyrrole-Imidazole Polyamide Is Active Against Enzalutamide-Resistant Prostate Cancer

Cancer Research
Cancer ResearchOncology
2017English

Anti-Tumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination With Enzalutamide in Prostate Cancer Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2020English

Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy

Klinicka Onkologie
Oncology
2016English

Mp52-01 Combination of Indomethacin and Enzalutamide to Treat Castration-Resistant Prostate Cancer

Journal of Urology
Urology
2018English

Eyeing Enzalutamide for Hormone-Sensitive Prostate Cancer

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy